Vaccine Hesitancy: Obstacles and Challenges.

IF 3.6 Q1 PEDIATRICS
Current pediatrics reports Pub Date : 2022-01-01 Epub Date: 2022-10-08 DOI:10.1007/s40124-022-00278-9
Preeti M Galagali, Aarti Avinash Kinikar, Vikram Sakaleshpur Kumar
{"title":"Vaccine Hesitancy: Obstacles and Challenges.","authors":"Preeti M Galagali,&nbsp;Aarti Avinash Kinikar,&nbsp;Vikram Sakaleshpur Kumar","doi":"10.1007/s40124-022-00278-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>In 2019, vaccine hesitancy (VH) was named as one of the top 10 threats to global health by the World Health Organization (WHO). We highlight the factors affecting VH, the role of VH in limiting vaccine uptake and inability to achieve collective immunity, and possible solutions.</p><p><strong>Recent findings: </strong>There are still uncertainties and concerns about the safety and efficacy of vaccines, which promote VH and undermine public confidence in immunization. WHO has designed the behavioral and social drivers (BeSD) tools and survey instruments that can be used by countries to assess reasons for poor vaccine uptake in childhood for COVID-19 and plan national vaccination programs to counter these misconceptions.</p><p><strong>Summary: </strong>Vaccines are one of the best preventative measures that public health care has to offer. Evidence from across the world both in high-income countries (HICs) and low/middle-income countries (LMICs) show that VH is a significant phenomenon which is translating into geographical clustering of epidemics. A reasonably high acceptance and coverage rates are necessary for an immunization program to be successful. A context-specific and multifactorial intervention with more high-quality research is needed globally.</p>","PeriodicalId":72740,"journal":{"name":"Current pediatrics reports","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546747/pdf/","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pediatrics reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40124-022-00278-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 14

Abstract

Purpose of review: In 2019, vaccine hesitancy (VH) was named as one of the top 10 threats to global health by the World Health Organization (WHO). We highlight the factors affecting VH, the role of VH in limiting vaccine uptake and inability to achieve collective immunity, and possible solutions.

Recent findings: There are still uncertainties and concerns about the safety and efficacy of vaccines, which promote VH and undermine public confidence in immunization. WHO has designed the behavioral and social drivers (BeSD) tools and survey instruments that can be used by countries to assess reasons for poor vaccine uptake in childhood for COVID-19 and plan national vaccination programs to counter these misconceptions.

Summary: Vaccines are one of the best preventative measures that public health care has to offer. Evidence from across the world both in high-income countries (HICs) and low/middle-income countries (LMICs) show that VH is a significant phenomenon which is translating into geographical clustering of epidemics. A reasonably high acceptance and coverage rates are necessary for an immunization program to be successful. A context-specific and multifactorial intervention with more high-quality research is needed globally.

Abstract Image

Abstract Image

疫苗犹豫:障碍和挑战。
审查目的:2019年,疫苗犹豫被世界卫生组织(世卫组织)列为全球健康的十大威胁之一。我们强调影响VH的因素,VH在限制疫苗摄取和无法实现集体免疫中的作用,以及可能的解决方案。最近的发现:疫苗的安全性和有效性仍存在不确定性和担忧,这促进了VH并破坏了公众对免疫接种的信心。世卫组织设计了行为和社会驱动因素(BeSD)工具和调查工具,各国可使用这些工具来评估儿童接种COVID-19疫苗不足的原因,并规划国家疫苗接种规划,以消除这些误解。摘要:疫苗是公共卫生保健所能提供的最好的预防措施之一。来自世界各地高收入国家和低收入/中等收入国家的证据表明,VH是一种重要现象,正在转变为流行病的地理聚集性。合理的高接受率和覆盖率是免疫规划成功的必要条件。在全球范围内,需要针对具体情况进行多因素干预,并开展更多高质量的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信